Calumet, Inc.

CLMT Basic Materials Specialty Chemicals

Calumet, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.1 billion, down 1.25% from fiscal 2024. In the quarter to June 2026, revenue grew 40.8%, EPS grew 35.9%, free cash flow grew 450.7% and total debt fell 1.98%, each against the same quarter a year earlier. Dividend growth for five consecutive years.

57.75 0.49 −0.84%
Market cap
$5.1B
P/E
0.0×
Fwd P/E
−9.0×
Dividend yield
—
F-score
5/9
Altman Z
1.16
Beneish M
−2.96
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
12.74% 19.82% 4.68% 5.67%

+8 more TTM periods

Piotroski F-Score
6 5 5 4
ROA
(4.90%) (6.77%) (1.24%) (1.44%)
ROIC
2.03% (0.61%) 4.64% 7.82%
Return on Tangible Assets
(12.14%) (14.51%) (2.47%) (2.65%)
Average Days of Receivables
33.15 31.35 20.51 25.13
Free Cash Flow per Share
0.84 0.05 0.65 (0.87)
Free Cash Flow
73.50 4.10 56.60 (75.60)
Capital Expenditures
(72.60) (47.90) (52.30) (64.60)
Other line items
Cash ROIC
4.20% 0.23% 3.02% (3.95%)
Accounts Receivable Turnover
12.70 12.61 16.20 13.86
Accounts Payable Turnover
13.17 11.93 12.92 11.98
Inventory Turnover
10.84 10.37 9.71 9.18
Average Days of Payables
31.66 32.79 26.40 29.34
Days of Inventory on Hand
35.82 34.29 36.13 39.30
Tax Rate
(0.50) (0.38) (0.73) (0.53)
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
4.90% 5.41% 4.15% 4.36%
Share Based Compensation of Revenue
0.98% 0.38% (0.17%) 0.00%
Interest Coverage
0.23 (0.07) 0.50 0.87
Operating CF/Net income
(1.07) (0.28) (3.22) 0.28
Depreciation/Fixed assets
0.25 0.24 0.35 0.00
Capex/Depreciation
(0.22) (0.15) (0.11) 0.00
Revenue per Share
52.42 47.97 47.68 46.58
Operating CF per Share
1.67 0.60 1.26 (0.13)
Capex per Share
(0.83) (0.55) (0.60) (0.74)
Capex to Sales
0.02 0.01 0.01 0.02

Fold the line items

Columns are period end dates